Thomas Charles Reilly's Net Worth
$171 Thousand
Who is Thomas Charles Reilly?
Thomas Charles Reilly does not have any significant net worth to report based on the numbers we have. This is based on reported shares across multiple companies, which include AMARIN CORP PLC\UK, and Cara Therapeutics, Inc..
SEC CIK
Thomas Charles Reilly's CIK is 0001827590
Past Insider Trading and Trends
2024 was Thomas Charles Reilly's most active year for acquiring shares with 7 total transactions. Thomas Charles Reilly's most active month to acquire stocks was the month of January. 2024 was Thomas Charles Reilly's most active year for disposing of shares, totalling 8 transactions. Thomas Charles Reilly's most active month to dispose stocks was the month of December. 2023 saw Thomas Charles Reilly paying a total of $436,752.00 for 908,801 shares, this is the most they've acquired in one year. In 2024 Thomas Charles Reilly cashed out on 223,936 shares for a total of $75,568.35, their largest year based on trade value.
Attention insiders: Dive deeper into market movements and stay ahead of the curve with Benzinga Pro! From up-to-the-second news to audio squawks and interactive data tools, it's everything you need to supercharge your trading strategy. Experience the Benzinga Pro advantage today and transform the way you trade with our exclusive free trial!
AMARIN CORP PLC\UK (AMRN) Snapshot price: $0.6094
EVP and CFO
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
| +9.85% | 8.46K |
$0.69 | -$5,664.21 | 94.31K |
Jul 1
| |||
Form 4
| +24.54% | 16.92K |
$0.73 | -$11,984.41 | 85.85K |
Jun 20
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Feb 1
| |||
Form 4
| +41.98% | 20.38K |
$1.24 | -$30,444.48 | 68.93K |
Jan 31
| |||
Form 4
| +91.33% | 23.18K |
$0.97 | -$27,475.25 | 48.55K |
Jan 10
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jul 19
| |||
Form 4
| +50.00% | 8.46K |
$1.19 | -$9,768.71 | 25.38K |
Jul 1
| |||
Form 4
|
∞
| 16.92K |
$1.19 | -$19,536.23 | 16.92K |
Jun 20
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Feb 21
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jul 1
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||
Cara Therapeutics, Inc. (CARA) Snapshot price: $0.3227
Chief Financial Officer
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
| -5.13% | -2.04K |
$11.38 | -$23,260.72 | 37.81K |
Scheduled
|
Mar 3
| ||
Form 4
| +174.45% | 25.33K |
$10.29 | $54,876.57 | 39.85K |
Feb 25 - Feb 28
| |||
Form 4
| +333.23% | 11.17K |
—
|
—
| 14.52K |
Dec 17
| |||
Form 4
| -37.16% | -1.98K |
$14.20 | -$28,144.40 | 3.35K |
Scheduled
|
Aug 30
| ||
Form 4
|
∞
| 5.33K |
—
|
—
| 5.33K |
Aug 24
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Oct 1
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||